Chemours Co (CC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows bullish technical indicators, positive analyst sentiment with multiple price target upgrades, and a favorable options sentiment. Despite some financial challenges, the company's valuation and diversification into refrigerants provide a strong case for long-term growth.
The stock exhibits bullish technical indicators with a positively expanding MACD histogram (0.119), bullish moving averages (SMA_5 > SMA_20 > SMA_200), and a price above key resistance levels (R1: 23.743). The RSI_6 at 79.277 is in the neutral zone, not signaling overbought or oversold conditions.

Multiple analyst price target upgrades, with the latest targets ranging from $25 to $29, indicating confidence in the stock's upward potential.
Diversification into refrigerants and higher North American exposure within TiO2, which analysts view as attractive.
Bullish technical indicators and favorable options sentiment.
Financial challenges in Q4 2025, including a revenue decline (-2.13% YoY) and a negative net income of -$61M, though net income improved significantly YoY.
Gross margin dropped significantly (-39.19% YoY), which could indicate cost pressures.
In Q4 2025, revenue declined by -2.13% YoY to $1.33B, while net income improved by 408.33% YoY to -$61M. EPS also increased by 412.50% YoY to -$0.41. However, gross margin dropped significantly to 11.95% (-39.19% YoY), reflecting potential cost challenges.
Analyst sentiment is highly positive, with multiple firms raising price targets recently. RBC Capital, UBS, Truist, and Mizuho all upgraded their price targets, with the highest being $29. Analysts cite lower supply driving price action, potential price uplift in petchems, and attractive valuation as key reasons for their optimism.